Tongue Cancer Completed Phase 2 Trials for DB01259 (Lapatinib)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00114283Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck CancerTreatment